Home · Healthcare · JNJ
J. TaubertEVP WWC Innovative Medicine
Executive Officer · Johnson & Johnson (JNJ)
FY2025 Compensation
Total Compensation FY2025
—
As reported in 2026 DEF 14A proxy filing with the SEC
Compensation Breakdown
Base Salary
$1.2M
0% of total
Stock Awards
—
0% of total
Bonus
—
0% of total
Other Compensation
$2.4M
0% of total
Data Source: Compensation figures are sourced from Johnson & Johnson's DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect total compensation for FY2025 as reported in the Summary Compensation Table.